Microbot Medical (MBOT) Azione Prezzo
Microbot Medical Prezzo
Negli ultimi 9 anni Microbot Medical ha aumentato il fatturato del 2,6% all'anno, raggiungendo 117.000,00 USD. Per Microbot Medical, il margine netto del -31.123,9% risulta in calo rispetto al -1746,8% di alcuni anni fa.
Microbot Medical Prezzo delle azioni
Accedi a questi dati tramite l’API Eulerpool
100.000 richieste/mese gratis · nessuna carta di credito
Microbot Medical Azione e analisi azionaria
Domande frequenti sull'azione Microbot Medical
Microbot Medical Inc's business model focuses on the development and commercialization of innovative transformational robotic solutions in the medical industry. The company specializes in creating miniature robots that can assist in minimally invasive surgeries, targeted drug delivery, and targeted endotherapy procedures. Microbot Medical Inc utilizes its proprietary technologies, including its Microbot Swarm system and ViRob robotic platform, to address critical unmet needs in various medical specialties. With its advanced robotic solutions, Microbot Medical Inc aims to improve patient outcomes, enhance surgical procedures, and provide physicians with more precise and efficient tools for diagnosis and treatment in the medical field.
Microbot Medical Inc is primarily active in the medical technology industry. As a cutting-edge company, Microbot Medical specializes in the development and commercialization of robotic technologies focused on improved medical procedures and treatments. With its innovative product portfolio, Microbot Medical aims to revolutionize various medical fields such as urology, neurology, and cardiovascular healthcare. Through its dedication to technological advancements and industry collaborations, Microbot Medical strives to provide healthcare professionals and patients with breakthrough solutions that enhance overall medical outcomes.
The main competitors of Microbot Medical Inc in the market include companies such as Medtronic, Intuitive Surgical, and Johnson & Johnson.
Microbot Medical Inc is a leading medical device company specializing in the development of transformational micro-robotic technologies. Established in 2010, Microbot Medical Inc aims to improve patient outcomes through the development of innovative robotic platforms designed for minimally invasive surgeries and targeted therapies. The company's cutting-edge technologies utilize advanced engineering and robotics to address significant unmet medical needs in various medical fields, including urology, gastroenterology, and ENT (ear, nose, and throat). With its commitment to revolutionizing medical interventions, Microbot Medical Inc continues to push boundaries in the field of robotic medicine, creating new possibilities for improved patient care.
Microbot Medical Inc has achieved several significant milestones. Firstly, the company successfully developed and received regulatory clearance for its innovative robotic technologies in the medical industry. Additionally, Microbot Medical Inc has made notable advancements in the fields of urology, neurology, and gastrointestinal procedures. The company has also successfully completed important clinical studies and collaborations with leading medical institutions. Moreover, Microbot Medical Inc has secured intellectual property rights for its proprietary technologies, which strengthens its position in the market. These milestones demonstrate the company's dedication to improving healthcare outcomes and solidify its reputation as a leader in the medical robotics field.
Microbot Medical Inc is primarily present in the United States, Israel, and Europe. This company, specializing in micro-robotics technologies, operates in multiple regions to distribute their innovative medical devices and solutions. Microbot Medical Inc's presence in these countries and regions enables them to reach a significant market and collaborate with leading medical institutions, professionals, and industry experts. By establishing a global footprint, Microbot Medical Inc aims to enhance patient outcomes and revolutionize the field of medical robotics.
Microbot Medical Inc represents values of innovation, advancement, and patient-centric healthcare solutions. With a strong corporate philosophy aimed at addressing unmet medical needs, Microbot Medical Inc is dedicated to developing and commercializing transformative robotic technologies. By combining novel engineering with medical expertise, the company aims to improve patient outcomes, reduce healthcare costs, and enhance overall quality of life. Microbot Medical Inc strives to empower physicians and healthcare professionals with cutting-edge tools and solutions, all while prioritizing patient safety and well-being.
9 analisti valutano attualmente l’azione Microbot Medical: 8 raccomandano l’acquisto, 1 la tenuta e 0 la vendita. Per il 2026 gli analisti si aspettano per Microbot Medical ricavi pari a 841.333,00 USD e un utile per azione di -0,06 USD.
Convertita al tasso di cambio attuale, l’azione Microbot Medical quota 0,85 EUR (0,95 USD).
L’azione Microbot Medical (MBOT) è quotata su 4 borse, tra cui: NASDAQ (MBOT), Frankfurt (CY9D.F), München (CY9D.MU), Düsseldorf (CY9D.DU).
Microbot Medical Inc is a leading company in the development and commercialization of miniature robots for medical applications. The company is based in Israel and also has branches in the USA.
Il attesa fatturato di Microbot Medical ammonta a 841.333,00 USD. Questo dato si basa sui dati finanziari attuali e riflette lo sviluppo commerciale dell'azienda.
Il attesa profitto di Microbot Medical ammonta a -4,21 Mio. USD. L'utile netto riflette la redditività dell'azienda dopo la deduzione di tutti i costi.
Il rapporto prezzo/utili (P/E) di Microbot Medical è attualmente -15,14. Il rapporto P/E confronta il prezzo attuale dell'azione con l'utile per azione e aiuta gli investitori a valutare la valutazione dell'azione Microbot Medical.
Il rapporto prezzo/fatturato (P/S) di Microbot Medical è attualmente 75,83. Il rapporto P/S confronta la capitalizzazione di mercato con il fatturato annuo e funge da indicatore di valutazione dell'azione Microbot Medical.
Il Quality Score AlleAktien per Microbot Medical è 2/10.
L'ISIN di Microbot Medical è US59503A2042. L'ISIN (International Securities Identification Number) è un codice identificativo univoco a livello mondiale per i titoli.
Il WKN di Microbot Medical è A2N5AS. Il WKN (Wertpapierkennnummer) è un codice identificativo tedesco a sei cifre per i titoli.
Il ticker di Microbot Medical è MBOT. Con questo simbolo di borsa vengono negoziate le azioni Microbot Medical in borsa.
Azione Microbot Medical
Gruppo di pari di Microbot Medical
Microbot Medical Ticker
Microbot Medical FIGI
Altre metriche e analisi di Microbot Medical in Deep Dive.
La nostra analisi azionaria dell'azione Microbot Medical include importanti indicatori finanziari come il fatturato, l'utile, il P/E, il P/S, l'EBIT, oltre a informazioni sul dividendo. Inoltre, esaminiamo aspetti come le azioni, la capitalizzazione di mercato, il debito, il patrimonio netto e le passività di Microbot Medical. Se state cercando informazioni più dettagliate su questi temi, sulle nostre sottopagine offriamo analisi approfondite: